The US foreign aid freeze causes disruption in the supply chain for vital medical products in poorer countries, affecting diseases like HIV and malaria. Other health updates include FDA drug approvals ...
US aid freeze affects HIV and malaria supply chains, FDA postpones rare disease events, and a leap in Texas measles cases. Meanwhile, Mirum Pharma's drug gets FDA approval, Eli Lilly invests in a ...
The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...
With U.S. President Donald Trump’s tariffs targeting imported pharmaceuticals, headaches lie ahead for both American patients ...
Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
How can pharmaceutical firms shore up their sustainability credentials at a time when the entire research landscape is turning on its head? A recent webinar from supply chain leaders World Courier and ...
India’s Contract Research, Development, and Manufacturing Organization industry is set to double to US$ 14 billion by 2028, driven by pharma outsourcing, regulatory support, and global supply chain ...
Congresswoman Claudia Tenney has reintroduced the Producing Incentives for Long-term Production of Lifesaving Supply of ...
With the Trump administration announcing plans to impose 25% tariffs on pharmaceuticals, it reignites a critical discussion ...
In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Laura Johnson, senior director of ...
Letter to Trump describes threats to healthcare delivery with potentially limited access to drugs, medication ingredients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback